Visit Invicro inside the REALM IDx Booth #3117 to speak with imaging experts and learn how our clinical expertise can help transform your cancer drug discovery and development.

    Visit us at ASCO

     

    Oral Abstract Session 
    Presenter: Andrew Armstrong, M.D. | Professor of Medicine, Duke University School of Medicine 
    Genitourinary Cancer | Hall D2 | Abstract #5002 
    Sunday, June 5, 8:24 AM CDT 

    [68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in pts with mCRPC: a VISION sub-study 

    Invicro co-authors:
    Phillip Kuo M.D., Ph.D. | Senior Medical Director
    Jacob Hesterman Ph.D. | Distinguished Scientist

    Your Full-Service Imaging CRO

    Invicro uniquely combines operational, scientific and medical expertise to support your cancer drug discovery and development pipelines.
    *Click titles below to learn more.*

    Radiopharmaceutical Therapy

    Complete solutions for streamlined development, evaluation and clinical translation of radiopharmaceuticals

    Clinical Imaging Core Lab

    Advanced scientific, medical and operational expertise to deliver global studies from Phase I-IV

     

    Research Imaging Services

    Molecular imaging solutions spanning from preclinical through late-phase clinical to support drug discovery and development 

    Advanced Pathology Services

    Custom biomarker assay validation, development and AI-powered image analysis services to gain spatial tissue insights

    Radiochemistry

    Primary method development for transfer from sponsor to label candidates, including biologics, small molecules, cells and more 

    Image Analytics

    Qualitative and quantitative image analytics for radiology and pathology studies, utilizing machine learning and artificial intelligence

     

    XXXXXXXXXXXXXX
    View Oncology Solutions

    © 2022 Invicro. LLC. All Rights Reserved. info@invicro.com | www.invicro.com